Determinants of Quality of Life in Patients with Immune-Checkpoint-Inhibitor Induced Secondary Adrenal Insufficiency

Clicks: 1
ID: 315263
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #315 of 360 articles by views in the journal of clinical endocrinology & metabolism

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 360 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Context Limited data are available on quality of life (QoL) and adrenal crises in patients with immune checkpoint inhibitor-induced secondary adrenal insufficiency (ICI-SAI). Objective To 1) characterize the presentation, management, and outcomes of patients with ICI-SAI; 2) compare outcomes of ICI-SAI with other etiologies of secondary adrenal insufficiency (oSAI); and 3) identify variables associated with QoL and adrenal crisis. Methods In this single-center cross-sectional study, adults with ICI-SAI or oSAI (2018-2025) completed questionnaires assessing symptoms, management, adrenal crises, and the Addison disease-specific QoL survey (AddiQoL). Outcomes AddiQoL score and adrenal crisis events Results Patients with ICI-SAI (n=109) were older (median age 66 vs 60 years), more often women (59% vs 43%), and more frequently diagnosed within one year of symptom onset (88% vs 42%, P<0.001), compared to patients with oSAI (n=139). Patients with ICI-SAI had higher AddiQoL scores (median 87 vs 85, P=0.020). In a multivariable analysis of age, sex, glucocorticoid dose and type, insurance support and duration of SAI, ICI-SAI remained independently associated with higher AddiQoL (estimate 5.4, P=0.010). The prevalence of reported adrenal crises within the prior year was similar between groups (15% vs 14%, P=0.782). In a multivariable analysis, higher AddiQoL scores were independently associated with lower odds of adrenal crisis (OR of 0.57, 95% CI 0.42-0.76). Conclusion Patients with ICI-SAI report better QoL compared with patients with other causes of SAI, despite similar adrenal crisis rates. These differences may be related to earlier diagnosis and differing clinical contexts, underscoring the importance of timeline recognition and patient-centered management.
Reference Key
openalex_W7162791747 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Justine Herndon, Yana Hleibiehova, Sara J Achenbach, Alexandra N Bancos, Elizabeth J Atkinson, Diane Donegan, Irina Bancos
Journal the journal of clinical endocrinology & metabolism
Year 2026
DOI
10.1210/clinem/dgag219
URL
https://doi.org/10.1210/clinem/dgag219
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.